Congratulations to this multidisciplinary research team co-lead by UBC Medicine's François Bénard and #SFUChemistry assistant professor Caterina Ramogida! They been awarded over $23 million in federal funding to develop new #radiopharmaceuticals to treat many different kinds of cancers, including end-stage metastatic cancers with few treatment options. https://www.med.ubc.ca/news/nuclear-medicine-can-cure-cancer-and-canadian-researchers-are-stepping-up-the-fight/ #oncology #nuclearmedicine #cancer

About 10 million nuclear medicine procedures are carried out in Europe every year.

#Radioisotopes & #radiopharmaceuticals are increasingly used for cancer treatment & care for cancer patients.

And Europe is the leading global supplier of medical radioisotopes.

🐦🔗: https://n.respublicae.eu/KadriSimson/status/1651518760640040960

RT @freddyeescorcia@twitter.com

Lots of folks in #nucmed and #radonc are interested in launching their own #radiopharmaceuticals ☢️therapy program, but not sure where to start.

If you're in this camp, you're in luck!🍀

@jmmrad@twitter.com and the team @WashURadOnc@twitter.com put together this comprehensive guide!

👇👇👇

🐦🔗: https://twitter.com/freddyeescorcia/status/1619770317756592132

Lots of folks in #nucmed and #radonc are interested in launching their own #radiopharmaceuticals ☢️therapy program, but not sure where to start.

If you're in this camp, you're in luck!🍀

@jmmrad@twitter.com and the team @WashURadOnc@twitter.com put together this comprehensive guide!

👇👇👇

Thanks for the kind words @OncoThor@twitter.com!

Trying to make #radiopharmaceuticals accessible to physicians to make them available for patients.

Grateful to @KilianSalerno@twitter.com @SouMyajiT_RO@twitter.com @RPatelMDPHD@twitter.com and coauthors, @ASTRO_org@twitter.com @IJROBP@twitter.com and @sueyom@twitter.com for the opportunity to publish our Primer!

#RadOnc #NucMed #Oncology #Oncodon @sueyom

🙏🚨I need your input🚨🙏

I was asked and agreed to write an updated book chapter on #radiopharmaceuticals therapy for the 8th Ed of Principles and Practice of Radiation Oncology (aka Perez and Brady).

What topics do you, my #RadOnc colleagues, want me to cover?

TIA!

Press release on PSMAfore trial, a ph3 study of pts with mCRPC randomized to switch of androgen receptor pathway inhibitor or 177Lu-PSMA tx.

✅1° endpt of sig improvement in radiographic PFS met
✅ no unexpected safety findings

https://www.novartis.com/news/media-releases/novartis-pluvictotm-shows-statistically-significant-and-clinically-meaningful-radiographic-progression-free-survival-benefit-patients-psma-positive-metastatic-castration-resistant-prostate-cancer

#radiopharmaceuticals

1/2

Excited to be launching this trial!

#livertwitter #livercancer #nucmed #radiopharmaceuticals

RT @PLOSONE@twitter.com

New #StudyProtocol from @freddyeescorcia@twitter.com and colleagues at @NCICCR_MIP@twitter.com: Functional Imaging of Liver Cancer (FLIC): Study protocol of a phase 2 trial of 18F-DCFPyL PET/CT imaging for patients with hepatocellular carcinoma

https://doi.org/10.1371/journal.pone.0277407

🐦🔗: https://twitter.com/PLOSONE/status/1598315990424633345

Can anyone help me understand the continued #radiopharmaceuticals work with girentuximab given that a phase 2 published in 2016 was underwhelming? 🤔🤷🏽‍♂️

I’m surely missing something.

#oncology #nucmed #radonc

https://www.sciencedirect.com/science/article/pii/S030228381501204X

@Kmachel

Nice! This recent paper in JACS might be of interest then: https://pubs.acs.org/doi/full/10.1021/jacs.2c08438

#oncology #radiopharmaceuticals #radonc #nucmed

#NET peeps might find the work of interest
@marklewismd@twitter.com @samira_sadowski@twitter.com @PamelaKunzMD@twitter.com @OncoThor@twitter.com @AmanChauhanMD@twitter.com @RPatelMDPHD@twitter.com @JaydiDelRivero@twitter.com @gwiezdzinska@twitter.com @NANETS1@twitter.com @CureNETs@twitter.com

#radonc #nucmed #radiopharmaceuticals #NETresearch

11/

Lu-dotatate changed how patients with SSTR+ NETs are treated.

Still, many patients have NETs that don’t respond or develop resistance to Lu-dotatate
#radiopharmaceuticals therapy.

Could alpha particle therapy help?

🧵 1/

@CureNETs@twitter.com @NANETS1@twitter.com #nucmed #radonc #oncology

CD8 immunoPET imaging as non-invasive biomarker for treatment response.

#radiopharmaceuticals #molecularimaging

RT @ASCOPost@twitter.com

Michael A. Postow, MD, on Using the Novel Radiotracer Crefmirlimab Berdoxam for Imaging to Assess Immunotherapy Responsiveness https://ascopost.com/videos/sitc-2022/michael-postow-on-using-the-novel-radiotracer-crefmirlimab-berdoxam-for-imaging-to-assess-immunotherapy-responsiveness/ #immunotherapy #oncology #cancer @Mpostow@twitter.com @MSKCancerCenter@twitter.com

🐦🔗: https://twitter.com/ASCOPost/status/1593954242359853057

@Kmachel def cool to explore here! Small world in #radiopharmaceuticals!

It can take YEARS before new #radiopharmaceuticals are translated to the clinic. Is there anything we can do in the meantime?

Could we evaluate approved agents for new indications?

Our trial aims to do just that.

🧵
1/

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0277407

#introductions

Hi Mastodonians!

I am an oncologist and scientist at the NCI developing #radiopharmaceuticals in the lab to help image and treat human cancers.

My research sits at the interface of #oncology #chemistry #radiochemistry #drugdevelopment #clinicaltrials #nucmed #radonc.

Beyond the professional, I enjoy #audiobooks, #fitness, #coffee, and occasional #beer #homebrewing.

Looking to connect with and learn from diverse thinkers in oncology, medicine, and beyond.